| Issue |
Title |
File |
| Vol 80, No 7 (2008) |
Pcr definition of b-cell clonality: which electrophoretic method is better |
|
|
Sidorova I.V., Nikitin E.A., Ryzhikova N.V., Sudarikov A.B.
|
| Vol 90, No 9 (2018) |
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases |
(Rus)
|
|
Lankin V.Z., Tikhaze A.K., Viigimaa M., Chazova I.E.
|
| Vol 93, No 11 (2021) |
Peculiarities of blood coagulation disorders in patients with COVID-19 |
(Rus)
|
|
Evtugina N.G., Sannikova S.S., Peshkova A.D., Safiullina S.I., Andrianova I.A., Tarasova G.R., Khabirova A.I., Rumyantsev A.G., Ataullakhanov F.I., Litvinov R.I.
|
| Vol 91, No 12 (2019) |
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease |
(Rus)
|
|
Mosina L.M., Stolyarova V.V., Esina M.V., Titojkina Y.V., Korobkov D.M.
|
| Vol 94, No 7 (2022) |
Peculiarities of hemostasis in patients with COVID-19 |
(Rus)
|
|
Kalinskaya A.I., Dukhin O.A., Molodtsov I.A., Anisimova A.S., Sokorev D.A., Elizarova A.K., Sapozhnikova O.A., Glebova K.A., Shakhidzhanov S.S., Spiridonov I.S., Ataullakhanov F.I., Shpektor A.V., Vasilieva E.Y.
|
| Vol 93, No 4 (2021) |
Peculiarities of Mild Asthma in Russia: the Results of SYGMA2 Study |
(Rus)
|
|
Aisanov Z.R., Avdeev S.N., Arkhipov V.V., Belevsky A.S., Voznesenskiy N.A.
|
| Vol 93, No 4 (2021) |
Peculiarities of sonoelastographic imaging of thyroid papillary cancer in presence of autoimmune thyroiditis |
(Rus)
|
|
Khachatryan A.R., Vardanyan G.J., Avetisyan G.A., Chomoyan A.S., Baghdasaryan S.E., Porksheyan K.A.
|
| Vol 79, No 6 (2004) |
Peculiarity of hypotensive efficacy in hypertensive patients with desaturation signs of obstructive sleep apnea syndrome |
|
|
Zelveian I.A., Oschepkova E.V., Buniatian M.S., Rogoza A.N.
|
| Vol 91, No 1 (2019) |
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks |
(Rus)
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Bayzhigitova A.A.
|
| Vol 96, No 4 (2024): Issues of diagnostics of internal diseases |
Performance of the left ventricular myocardium in patients with a negative test result during exercise stress echocardiography |
(Rus)
|
|
Alekhin M.N., Radova N.F., Leshchinskaia S.P., Ivanov S.I.
|
| Vol 88, No 7 (2016) |
Perianal infection in patients with hemoblastosis: Risk factors and possibilities of prevention |
(Rus)
|
|
Shtyrkova S.V., Klyasova G.A., Ntanishyan K.I., Gemdzhian E.G., Troitskaya V.V., Karagyulyan S.R.
|
| Vol 92, No 12 (2020) |
Pericarditis in contemporary therapeutic clinic: nosological spectrum, approaches to diagnosis and treatment |
(Rus)
|
|
Blagova O.V., Nedostup A.V., Sedov V.P., Kogan E.A., Alijeva I.N., Sorokin G.Y., Sarkisova N.D.
|
| Vol 91, No 12 (2019) |
Peripheral nervous system lesion in systemic vasculitis - issues of diagnosis and treatment |
(Rus)
|
|
Golovach I.Y., Yehudina Y.D.
|
| Vol 88, No 5 (2016) |
Peripheral vessel wall changes in hypertensive patients with gout |
(Rus)
|
|
Shelest B.A.
|
| Vol 79, No 10 (2004) |
Periportal cardiomyopathy (a case report) |
|
|
Pavlov V.V., Lineva О.I., Khutorskaya N.N., Agafonova О.V., Vanyagina Z.P., Zubrilkina L.G.
|
| Vol 86, No 1 (2014) |
Peroxisome proliferator-activated receptors-alpha (PPAR-α) and chronic heart failure: Is there a reason to discuss the metabolic strategy of treatment? |
|
|
Zhirov I.V., Zaseeva A.V., Masenko V.P., Tereshchenko S.N.
|
| Vol 85, No 9 (2013) |
Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches |
|
|
Rasin M.S.
|
| Vol 97, No 4 (2025): Вопросы диагностики |
Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region |
(Rus)
|
|
Dolgushina A.I., Saenko A.A., Osaulenko V.V., Sluchanko A.S., Khusainova G.M., Sarsenbaeva A.S., Novitskaya E.Z., Zlakazova A.Y., Merkulova S.A., Vasilenko A.G.
|
| Vol 79, No 5 (2004) |
Persistence of various infective agents in blood mononuclear leukocytes in debute of rheumatoid arthritis |
|
|
Petrov A.V., Dudar L.V., Maly K.D.
|
| Vol 97, No 8 (2025): Treatment issues |
Personalised treatment of patients with immune thrombotic thrombocytopenic purpura |
(Rus)
|
|
Galstyan G.M., Klebanova E.E., Mamleeva S.Y., Avdonin P.V., Fidarova Z.T., Drokov M.Y., Parovichnikova E.N.
|
| Vol 91, No 7 (2019) |
Personalized approach for direct oral anticoagulant prescription: from theory to practice |
(Rus)
|
|
Skripka A.I., Kogay V.V., Listratov A.I., Sokolova A.A., Napalkov D.A., Fomin V.V.
|
| Vol 96, No 8 (2024): Treatment issues |
Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry |
(Rus)
|
|
Maev I.V., Yurenev G.L., Barkalova E.V., Ovsepian M.A., Andreev D.N., Shaburov R.I.
|
| Vol 90, No 2 (2018) |
Personalized medicine in the treatment of inflammatory bowel diseases |
(Rus)
|
|
Parfenov A.I., Knyazev O.V., Kagramanova A.V., Fadeeva N.A.
|
| Vol 90, No 4 (2018) |
Personalized strategies in reproductive medicine for patients with endocrine disorders |
(Rus)
|
|
Grigoryan O.R., Andreeva E.N., Dedov I.I.
|
| Vol 86, No 10 (2014) |
Personalized therapy for diabetes mellitus: the path from disease to the patient |
|
|
Dedov I.I., Shestakova M.V.
|
| Vol 84, No 6 (2012) |
PERSONIFICATED MEDICINE IN CLINICAL NEPHROLOGY |
|
|
Mukhin N.A., Fomin V.V.
|
| Vol 92, No 4 (2020) |
Perspectives of cell therapy for myocardial infarction and heart failure based on cardiosphere cells |
(Rus)
|
|
Dergilev K.V., Vasilets I.D., Tsokolaeva Z.I., Zubkova E.S., Parfenova E.V.
|
| Vol 84, No 1 (2012) |
Perspectives of molecular visualization in cardiology |
|
|
Sergienko V.B., Samoylenko L.E., Sergienko V.B., Samoilenko L.E.
|
| Vol 83, No 11 (2011) |
Perspectives of prevention and treatment of Herpes Symplex with regular recurrence |
|
|
Isakov V.A., Ermolenko D.K., Isakov D.V., Isakov V.A., Ermolenko D.K., Isakov D.V.
|
| Vol 80, No 5 (2008) |
Perspectives of rheumatology in the XXI century |
|
|
Nasonova V.A.
|
| Vol 83, No 5 (2011) |
Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century |
|
|
Nasonov E.L., Nasonov E.L.
|
| Vol 90, No 1 (2018) |
Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension |
(Rus)
|
|
Simakova M.A., Ryzhkov A.V., Kazymly A.V., Naimushin A.V., Lukinov V.L., Moiseeva O.M.
|
| Vol 91, No 7 (2019) |
PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients |
(Rus)
|
|
Solovev M.V., Mendeleeva L.P., Firsova M.V., Aslanidi I.P., Mukhortova O.V., Savchenko V.G.
|
| Vol 90, No 11 (2018) |
Pets in modern society: hidden threats |
(Rus)
|
|
Malov V.A., Maleyev V.V.
|
| Vol 81, No 7 (2009) |
Pharmacodynamic characteristics of velkeid efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins |
|
|
Golenkov A.K., Mitina T.A., Kogarko I.N., Lyubimova N.V., Klinushkina E.F., Baryshnikov A.Y., Golenkov A.K., Mitina T.A., Kogarko I.N., Lyubimova N.V., Klikushkina E.F., Baryshnikov A.Y.
|
| Vol 89, No 3 (2017) |
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension |
(Rus)
|
|
Moisseeva O.M., Rudakova A.V.
|
| Vol 95, No 1 (2023) |
Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19 |
(Rus)
|
|
Zhuravleva M.V., Chulanov V.P., Gagarina J.V., Shabalina E.A.
|
| Vol 86, No 8 (2014) |
Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases |
|
|
Samsonov A.A., Grechushnikov V.B., Andreev D.N., Iurenev G.L., Korovina T.I., Lezhneva I.A., Maev I.V.
|
| Vol 94, No 7 (2022) |
Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation |
(Rus)
|
|
Zyryanov S.K., Dyakov I.N., Aisanov Z.R.
|
| Vol 94, No 12 (2022) |
Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome |
(Rus)
|
|
Davidov E.L., Yaskevich R.A.
|
| Vol 93, No 11 (2021) |
Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020 |
(Rus)
|
|
Pshenichnaya N.Y., Kareva E.N., Leneva I.A., Bulgakova V.A., Kravchenko I.E., Nikolaeva I.V., Grekova A.I., Ivanova A.P., Puzyreva L.V., Khasanova G.M., Orlova S.N., Tikhonova E.P., Petrov V.A., Malinin O.V., Kolaeva N.V., Volchkova E.V., Kanshina N.N., Chulanov V.P.
|
| Vol 89, No 1 (2017) |
Pharmacoepidemiological study of the course of influenza and other acute respiratory viral infections in risk groups |
(Rus)
|
|
Bulgakova V.A., Poromov A.A., Grekova A.I., Pshenichnaya N.Y., Selkova E.P., Lvov N.I., Leneva I.A., Shestakova I.V., Maleev V.V.
|
| Vol 82, No 12 (2010) |
Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis |
|
|
Konenkov V.I., Zonova E.V., Korolev M.A., Leonova Y.B., Shevchenko A.V., Golovanova O.V., Prokof'ev V.F., Konenkov V.I., Zonova E.V., Korolev M.A., Leonova Y.B., Shevchenko A.V., Golovanova O.V., Prokofyev V.F.
|
| Vol 84, No 9 (2012) |
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism |
|
|
Lavrenko A.V., Shlykova O.A., Kutsenko L.A., Mamontova T.V., Kaĭdashev I.P.
|
| Vol 96, No 1 (2024): Outpatient care issues and organization of medical care |
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review |
(Rus)
|
|
Samoilova I.G., Vaizova O.E., Stankova A.E., Matveeva M.V., Podchinenova D.V., Kudlay D.A., Borozinets A.A., Filippova T.A., Grishkevich I.R., Partala A.V., Gerasimova D.A.
|
| Vol 83, No 12 (2011) |
Pharmacokinetic and pharmacodynamic characteristics of antihypertensive drugs in the treatment of hypertensive patients with chronic diseases of the liver |
|
|
Mikheeva O.M., Drozdov V.N., Komisarenko I.A., Mikheeva O.M., Drozdov V.N., Komisarenko I.A.
|
| Vol 94, No 12 (2022) |
Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review |
(Rus)
|
|
Bakulina N.V., Tikhonov S.V., Okovityi S.V., Lutaenko E.A., Bolshakov A.O., Prikhodko V.A., Nekrasova A.S.
|
| Vol 92, No 2 (2020) |
Pharmacological and clinical feature of rebamipide: new therapeutic targets |
(Rus)
|
|
Zvyaglova M.Y., Knyazev O.V., Parfenov A.I.
|
| Vol 84, No 4 (2012) |
PHARMACOLOGICAL CORRECTION OF HEART RATE IN MYOCARDIAL ISCHEMIA |
|
|
Astashkin E.I., Glezer M.G.
|
| Vol 84, No 6 (2012) |
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE) |
|
|
Nikolaev A.Y.
|
| 2751 - 2800 of 4220 Items |
<< < 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 > >> |
